Home » Stocks » ENDP

Endo International PLC (ENDP)

Stock Price: $5.43 USD -0.15 (-2.69%)
Updated May 6, 2021 4:00 PM EDT - Market closed
After-hours: $5.58 +0.15 (2.76%) May 6, 6:00 PM
Market Cap 1.30B
Revenue (ttm) 2.90B
Net Income (ttm) 183.94M
Shares Out 233.30M
EPS (ttm) 0.79
PE Ratio 6.89
Forward PE 2.70
Dividend n/a
Dividend Yield n/a
Trading Day May 6
Last Price $5.43
Previous Close $5.58
Change ($) -0.15
Change (%) -2.69%
Day's Open 5.58
Day's Range 5.26 - 5.66
Day's Volume 3,854,159
52-Week Range 2.71 - 10.89

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

DUBLIN, May 6, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2021. "I am proud of the continued strong execution acros...

2 hours ago - PRNewsWire

TORONTO, May 3, 2021 /PRNewswire/ - Maverix Private Equity, a Toronto-based private equity firm which recently announced an inaugural USD $500 million growth-fund, has today announced the addition of Mi...

3 days ago - PRNewsWire

Endo (ENDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

1 week ago - Zacks Investment Research

DUBLIN, April 29, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that data relevant to the use of Endo Aesthetics' Qwo® (collagenase clostridium histolyticum-aaes), which rec...

1 week ago - PRNewsWire

Mark Barberio appointed Chairman of the Board of Directors effective at 2021 Annual General Meeting DUBLIN, April 27, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo" or the "Company")...

1 week ago - PRNewsWire

Four drugmakers helped cause the deadly U.S. opioid epidemic by deceptively marketing their drugs and downplaying their addictive risks, a lawyer for several California counties argued on Monday at the ...

Other stocks mentioned: JNJ, ABBV, TEVA
2 weeks ago - Reuters

DUBLIN, April 13, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2021 financial results on May 6, 2021 and members of its senior management team will host a c...

3 weeks ago - PRNewsWire

DUBLIN, April 13, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that Phase 3 data evaluating Qwo® (collagenase clostridium histolyticum-aaes) for the treatment of moderate t...

3 weeks ago - PRNewsWire

DUBLIN, April 7, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the entry of an order granting a default judgment on liability against its wholly-owned subsidiaries Endo Heal...

4 weeks ago - PRNewsWire

Endo (ENDP) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

Valuation is a big part of security analysis. But before choosing a valuation model and begin crunching numbers, security analysts must understand how the company behind an equity security creates value.

1 month ago - GuruFocus

DUBLIN, March 11, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that its wholly-owned subsidiaries Endo Luxembourg Finance Company I S.à r.l. ("Endo Luxembourg") an...

1 month ago - PRNewsWire

DUBLIN, March 11, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that its wholly-owned subsidiaries Endo Luxembourg Finance Company I S.à r.l. ("Endo Luxembourg") an...

1 month ago - PRNewsWire

DUBLIN, March 4, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that it has commenced a refinancing of its existing $3.3 billion senior secured term loan due 2024 wi...

2 months ago - PRNewsWire

Endo's (ENDP) earnings and sales beat estimates in the fourth quarter.

2 months ago - Zacks Investment Research

DUBLIN, Feb. 25, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2020 and introduced 2021 financial gu...

2 months ago - PRNewsWire

If you want to increase your chances of beating the market, one method is to select stocks that rank highly according to the "Magic Formula" criteria.

Other stocks mentioned: GIB, SIGA
2 months ago - GuruFocus

DUBLIN, Feb. 17, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan 2021 Global High Yield & Leveraged Finance Conferen...

2 months ago - PRNewsWire

DUBLIN, Feb. 17, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its Board of Directors has appointed Jennifer M. Chao to serve as a director, effective immediately. Ms. ...

2 months ago - PRNewsWire

Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 months ago - Zacks Investment Research

DUBLIN, Jan. 26, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2020 financial results on February 25, 2021 after the market closes and members...

3 months ago - PRNewsWire

Does Endo International (ENDP) have what it takes to be a top stock pick for momentum investors? Let's find out.

3 months ago - Zacks Investment Research

DUBLIN, Dec. 18, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 ...

4 months ago - PRNewsWire

Endo (ENDP) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

DUBLIN, Nov. 18, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that the Company will participate in two investor conferences. Members of management will participate in the 2...

5 months ago - PRNewsWire

Is Endo International (ENDP) a great pick from the value investor's perspective right now? Read on to know more.

5 months ago - Zacks Investment Research

Endo International plc (ENDP) CEO Blaise Coleman on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Endo's (ENDP) earnings and sales beat estimates in the third quarter. The company raises its annual outlook.

6 months ago - Zacks Investment Research

Endo (ENDP) delivered earnings and revenue surprises of 271.43% and 13.72%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

DUBLIN, Nov. 5, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2020. "Our third-quarter 2020 results reflect growth...

6 months ago - PRNewsWire

- Initiatives to Enable Company to Reinvest in Key Areas of Growth - DUBLIN, Nov. 5, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the initiation of several strategic action...

6 months ago - PRNewsWire

GOTHENBURG, Sweden, Nov. 2, 2020 /PRNewswire/ -- Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) is pleased to announce today a definitive license agreement with ...

6 months ago - PRNewsWire

GOTHENBURG, Sweden, Nov. 2, 2020 /PRNewswire/ -- Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) has today announced a definitive licensing agreement with Endo Ve...

6 months ago - PRNewsWire

DUBLIN, Nov. 2, 2020 /PRNewswire/ -- Endo International plc (Nasdaq: ENDP) ("Endo") today announced that Endo's wholly-owned indirect subsidiary, Beta Acquisition Corp. ("Merger Sub"), has commenced its...

6 months ago - PRNewsWire

Endo (ENDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

6 months ago - Zacks Investment Research

New York, New York--(Newsfile Corp. - October 21, 2020) - [DATELINE]Rowley Law PLLC is investigating potential securities law violations by BioSpecifics Technologies Corp. (NASDAQ: BSTC) and its board o...

Other stocks mentioned: BSTC
6 months ago - Newsfile Corp

Endo (ENDP) gains from the acquisition of commercial-stage biopharmaceutical company, BioSpecifics Technologies Corp.

6 months ago - Zacks Investment Research

Investors are fired up about Endo's planned acquisition of BioSpecifics.

Other stocks mentioned: BSTC
6 months ago - The Motley Fool

News that Endo International PLC (NASDAQ: ENDP) would acquire BioSpecifics Technologies Corp.

Other stocks mentioned: BSTC
6 months ago - 24/7 Wall Street

WILMINGTON, Del., Oct. 19, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC) announced today that it has entered into a definitive merger agreement under which Endo International plc (...

Other stocks mentioned: BSTC
6 months ago - PRNewsWire

-- Endo to acquire BioSpecifics in an accretive all-cash transaction -- DUBLIN, Oct. 19, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced it has agreed to acquire all of the ou...

Other stocks mentioned: BSTC
6 months ago - PRNewsWire

DUBLIN, Oct. 9, 2020 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced that data relevant to the use of Endo Aesthetics' Qwo™ (collagenase clostridium histolyticum-aaes) for the treat...

6 months ago - PRNewsWire

DUBLIN, Oct. 7, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its third–quarter 2020 financial results on November 5, 2020 after the market closes and members of its senior ma...

6 months ago - PRNewsWire

Investors need to pay close attention to Endo (ENDP) stock based on the movements in the options market lately.

6 months ago - Zacks Investment Research

DUBLIN, Oct. 6, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the release of its first Environmental, Social and Governance (ESG) report, titled 2019 Corporate Responsibilit...

7 months ago - PRNewsWire

DUBLIN, Oct. 1, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Pharmaceutical, Inc. (Par), has begun shipping sapropterin dihydrochloride tablets, 10...

7 months ago - PRNewsWire

Endo (ENDP) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

7 months ago - Zacks Investment Research

Novavax Inc. (NASDAQ: NVAX) said that Endo International (NASDAQ: ENDP) will be in charge of manufacturing its COVID-19 vaccine after the two companies inked a non-exclusive agreement on Friday. Earlier...

Other stocks mentioned: NVAX
7 months ago - Invezz

About ENDP

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated f... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Sep 25, 1996
Stock Exchange
NASDAQ
Ticker Symbol
ENDP
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 15 analysts, the average rating for ENDP stock is "Hold." The 12-month stock price forecast is 7.70, which is an increase of 41.80% from the latest price.

Price Target
$7.70
(41.80% upside)
Analyst Consensus: Hold